First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Clinical trial NCT04504669 · COMPLETED

Trial details

NCT number: NCT04504669
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Cancer Non-Small-Cell Lung Cancer Triple Negative Breast Neoplasms Squamous Cell Cancer of Head and Neck Small Cell Lung Cancer Gastroesophageal Cancer Melanoma Cervical Cancer Advanced Solid Tumours

Start date: 2020-08-18
Primary completion: 2024-10-07
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.